Table 2: Clinical outcome data.
|
Total (n = 257) |
BSC I (n = 153) |
BSC II (n = 104) |
p-value |
| KS at 1-year follow-up§
|
90 (89 – 91) |
90 (89 – 90) |
91 (90 – 92) |
0.035 |
| KS at final follow-up§
|
91 (90 - 91) |
90 (89 – 91) |
91 (90 – 92) |
0.003 |
| FS at 1-year follow-up§
|
88 (87 – 99) |
87 (86 – 88) |
89 (88 – 91) |
0.027 |
| FS at final follow-up§
|
88 (87 – 89) |
88 (86 – 89) |
88 (86.5 – 88.9) |
0.367 |
| ROM at 1-year follow-up§
|
125 (123 – 126) |
123 (121 – 124) |
127 (125 – 129) |
0.001 |
| WOMAC at final follow-up§
|
23 (23 – 24) |
23 (23 – 24) |
23 (22 – 24) |
0.359 |
| HKA Angle* |
1.3 ± 1.1 |
1.3 ± 1.2 |
1.2 ±1.0 |
0.740 |
Presented as mean (95% confidence interval) § or mean ± standard deviation*. Abbreviations: KS = Knee Score; FS = Function Score; ROM = range of motion; HKA = hip-knee-ankle.